Launch excellence for diabetes medicines

Download Type: Adobe PDF

Sarah Rickwood and Carolyn Gauntlett from the European Thought Leadership Group IMS Health discuss the market for non-insulin diabetes treatments.


They discuss the market for first DPP-IV inhibitors and another major new class, the SGLT-2s.

Share this download

More services